Inicio › Cáncer metastásico › Texas
Ensayos clínicos de Cáncer metastásico en Texas
139 estudios sobre Cáncer metastásico buscan participantes en Texas.
Ciudades en Texas
- Houston104 estudios
- San Antonio44 estudios
- Dallas42 estudios
- Austin19 estudios
- Irving11 estudios
- The Woodlands9 estudios
- League City7 estudios
- Fort Worth7 estudios
- McAllen5 estudios
- El Paso5 estudios
- Tyler5 estudios
- Abilene5 estudios
- Killeen4 estudios
- Sugar Land4 estudios
- Lewisville3 estudios
- Pearland3 estudios
- Brownsville3 estudios
- Pharr3 estudios
- Beaumont3 estudios
Texto oficial del estudio (inglés)
A Study of ASP3082 in Adults With Advanced Solid Tumors
- NEXT Oncology, San Antonio
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 30 sept 2026 · NCT05382559A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
- ALX Center 5, Houston
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 30 sept 2026 · NCT07085091Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
- Texas Oncology- Baylor Charles A. Sammons Cancer Center, Dallas
ReclutandoFase 2/3
Edades de 18 en adelante · Todos los sexos · Actualizado el 29 sept 2026 · NCT06943755First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors
- University of Texas M.D. Anderson Cancer Center, Houston
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 29 sept 2026 · NCT05875168Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- Hendrick Medical Center, Abilene
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
- Lyndon Baines Johnson General Hospital, Houston
- y 2 más
ReclutandoFase 2
Todas las edades · Todos los sexos · Actualizado el 29 sept 2026 · NCT05564377Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
- Texas Oncology - West Texas, Abilene
- Texas Oncology - West Texas, Amarillo
- Texas Oncology - Gulf Coast, Beaumont
- y 27 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 28 sept 2026 · NCT07222800A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
- START Dallas Fort Worth, Fort Worth
- MD Anderson, Houston
- NEXT Oncology Houston, Houston
- y 1 más
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 28 sept 2026 · NCT07277413A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
- NEXT Oncology, Austin
- UT Southwestern, Dallas
ReclutandoFase 1
Edades de 19 en adelante · Todos los sexos · Actualizado el 28 sept 2026 · NCT06586957A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- University of Texas Southwestern Medical Center - Simmons Cancer Center, Dallas
- University of Texas Southwestern Medical Center-William P. Clements Jr. University Hospital, Dallas
- University of Texas Southwestern Medical Center-Zale Lipshy University Hospital, Dallas
- y 3 más
ReclutandoFase 2/3
Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT06989437Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- Texas Oncology - West Texas, Abilene
- Texas Oncology - Northeast Texas, Allen
- Texas Oncology - West Texas, Amarillo
- y 52 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT07222566A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
- Research Site, Dallas
- Research Site, El Paso
- Research Site, Sugar Land
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT06103864ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
- University of Texas Southwestern Medical Center, Dallas
- Houston Methodist Cancer Center, Houston
- The University of Texas M.D. Anderson Cancer Center, Houston
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT07007559A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors
- NEXT Oncology, Austin
- NEXT Oncology, Dallas
- SCRI at Mary Crowley, Dallas
- y 3 más
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT07612176Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
- Texas Oncology - West Texas, Abilene
- Texas Oncology - Austin, Austin
- Texas Oncology - San Antonio, San Antonio
- y 1 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT07562152A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
- The University of Texas Southwestern Medical Center - Harold C Simmons Comprehensive Cancer Center, Dallas
- Baylor College of Medicine, Houston
ReclutandoFase 1/2
Hasta los 25 · Todos los sexos · Actualizado el 25 sept 2026 · NCT04094610Parenting Support Intervention for Families Coping With Metastatic or Locally Recurrent Solid Tumor Diagnosis
- M D Anderson Cancer Center, Houston
ReclutandoSe aceptan voluntarios sanos
Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT05059678Intratumoral N17350 in Advanced Solid Tumors
- The University of Texas MD Anderson Cancer Center, Houston
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 23 sept 2026 · NCT07339176Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- MD Anderson, Houston
- NEXT Dallas, Irving
- NEXT Oncology San Antonio, San Antonio
- y 1 más
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT06128551A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
- USO-Texas Oncology-Central/South Texas, Austin
- World Research Link, Baytown
- Parkland Health and Hospital System, Dallas
- y 5 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07218380Prospective External Control Cohort In Patients With Newly Diagnosed Advanced or Metastatic EGFR Mutant Non-Small Cell Lung Cancer
- Oncology Consultants, P.A., Houston
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07028489SLV-154 Treatment of Advanced Cancers
- MD Anderson Cancer Center, Houston
- Oncology Consultants, Houston
- Mays Cancer Center; University of Texas Health San Antonio, San Antonio
ReclutandoFase 1
Edades de 12 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT06771219A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
- Hendrick Medical Center, Abilene
- World Research Link, Baytown
- Parkland Health and Hospital System, Dallas
- y 10 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07174336A Study of LY4257496 in Participants With Cancer (OMNIRAY)
- Texas Oncology - DFW (Sammons CC), Dallas
- MD Anderson Cancer Center, Houston
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07114601EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors
- START Dallas Fort Worth, Fort Worth
- University of Texas MD Anderson Cancer Center, Houston
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07262619A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
- USO-Texas Oncology-Central/South Texas, Austin
- UT Southwestern Medical Center, Dallas
- US Oncology, The Woodlands
- y 1 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07213804AMG 436 as Monotherapy and Combination Therapy in Participants With MSI-H/dMMR Solid Tumors
- Next Oncology - Dallas, Irving
ReclutandoFase 1
Edades de 18 a 99 · Todos los sexos · Actualizado el 21 sept 2026 · NCT07403721A Study to Assess Safety and Efficacy of SOT109 in Patients With Advanced Unresectable or Metastatic Colorectal Cancer
- NEXT Houston, Houston
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 21 sept 2026 · NCT07693751A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
- The University of Texas MD Anderson Cancer Center - Texas Medical Center, Houston
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 21 sept 2026 · NCT07629960Talazoparib and Palbociclib, Axitinib, or Crizotinib for the Treatment of Advanced or Metastatic Solid Tumors, TalaCom Trial
- M D Anderson Cancer Center, Houston
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 18 sept 2026 · NCT04693468Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
- Texas Oncology (Balcones) - SCRI, Austin
- MD Anderson Cancer Center, Houston
- START South Texas Accelerated Research Therapeutics, San Antonio
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 18 sept 2026 · NCT05267626Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
- Texas Oncology - Central South, Austin
- Texas Oncology - Central South, Austin
- Texas Oncology - Central South, Austin
- y 26 más
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 17 sept 2026 · NCT07227415Triage of Advanced Cervical Cancer Through Immunotherapy Induction (TRACTION)
- M D Anderson Cancer Center, Houston
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 17 sept 2026 · NCT05475171Study of ISM6331 in Participants With Advanced/Metastatic Mesothelioma or Other Advanced Solid Tumors
- NEXT Oncology - Austin, Austin
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 16 sept 2026 · NCT06566079The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- New Experimental Therapeutics - NEXT Oncology, Austin
- Texas Oncology, Bedford
- UT Southwest Simmons Cancer Center, Dallas
- y 2 más
ReclutandoFase 1/2
Edades de 12 en adelante · Todos los sexos · Actualizado el 15 sept 2026 · NCT04585750CREO - Microwave Ablation Feasibility Study
- Memorial Hermann-Texas Medical Center, Houston
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 14 sept 2026 · NCT07817147A Clinical Study of MK-8294 in Participants With Advanced Solid Tumors (MK-8294-001)
- Houston Methodist Hospital ( Site 0103), Houston
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 11 sept 2026 · NCT07030712A Study of KK2269 in Adult Participants With Solid Tumors
- The University of Texas Southwestern Medical Center, Dallas
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 10 sept 2026 · NCT06266299CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
- Clinical Study Site, Dallas
- Clinical Study Site, San Antonio
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 10 sept 2026 · NCT07335497Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma
- University of Texas - MD Anderson Cancer Center, Houston
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 9 sept 2026 · NCT05287945A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
- UT MD Anderson, Houston
- NEXT Oncology, San Antonio
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 9 sept 2026 · NCT06440005De ClinicalTrials.gov, datos obtenidos el 1 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.